Diagnosis of secondary hypertension: An age-based approach

American Family Physician

Volumn 82, Issue 12, 2010, Pages 1471-1478

  Viera, Anthony J ^a   Neutze, Dana M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CORTICOSTEROID; DEXAMETHASONE; RENIN;

AGE DISTRIBUTION; ALDOSTERONE BLOOD LEVEL; ANGIOGRAPHY; AORTA COARCTATION; ARTICLE; BLOOD PRESSURE MONITORING; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; FIBROMUSCULAR DYSPLASIA; FLUSHING; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; LABORATORY TEST; LOW DRUG DOSE; NEPHROSCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PLASMA RENIN ACTIVITY; POLYSOMNOGRAPHY; RENOGRAPHY; SLEEP APNEA SYNDROME; SWEATING; THYROID DISEASE; URINALYSIS; ADRENAL TUMOR; DIFFERENTIAL DIAGNOSIS; REVIEW;

ADRENAL GLAND NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FIBROMUSCULAR DYSPLASIA; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; PHEOCHROMOCYTOMA; RENAL ARTERY OBSTRUCTION;

EID: 79952279122     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44(4):398-404.
2. Rudnick KV, Sackett DL, Hirst S, Holmes C. Hypertension in a family practice. Can Med Assoc J. 1977;117(5):492-497.
3. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27(3):193-202.
4. U.S. Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Revised May 2005. NIH Publication No. 05-5267. http://www.nhlbi.nih.gov/health/prof/heart/hbp/hbp_ped.pdf. Accessed July 16, 2010.
5. Chobanian AV, Bakris GL, Black HR, et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252.
6. Pemberton J, Sahn DJ. Imaging of the aorta. Int J Cardiol. 2004;97(suppl 1):53-60.
7. Elliott WJ. Renovascular hypertension: an update. J Clin Hypertens (Greenwich). 2008;10(7):522-533.
8. Krijnen P, van Jaarsveld BC, Steyerberg EW, Man in't Veld AJ, Schalekamp MA, Habbema JD. A clinical prediction rule for renal artery stenosis. Ann Intern Med. 1998;129(9):705-711.
9. Tan KT, van Beek EJ, Brown PW, van Delden OM, Tijssen J, Ramsay LE. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol. 2002;57(7):617-624.
10. Rountas C, Vlychou M, Vassiou K, et al. Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler US, CT angiography, GD-enhanced MR angiography, and digital substraction angiography. Ren Fail. 2007;29(3):295-302.
11. Zhang HL, Sos TA, Winchester PA, Gao J, Prince MR. Renal artery stenosis: imaging options, pitfalls, and concerns. Prog Cardiovasc Dis. 2009;52(3):209-219.
12. Eklöf H, Ahlström H, Magnusson A, et al. A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol. 2006;47(8):764-774.
13. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287(11):1427-1434.
14. Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab. 2008;93(5):1553-1562.
15. Nihoyannopoulos P, Karas S, Sapsford RN, Hallidie-Smith K, Foale R. Accuracy of two-dimensional echocardiography in the diagnosis of aortic arch obstruction. J Am Coll Cardiol. 1987;10(5):1072-1077.
16. Nishizaka MK, Pratt-Ubunama M, Zaman MA, Cofield S, Calhoun DA. Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. Am J Hypertens. 2005;18(6):805-812.
17. Flemons WW, Whitelaw WA, Brant R, Remmers JE. Likelihood ratios for a sleep apnea clinical prediction rule. Am J Respir Crit Care Med. 1994;150(5 pt 1):1279-1285.
18. Page JE, Morgan SH, Eastwood JB, et al. Ultrasound findings in renal parenchymal disease: comparison with histological appearances. Clin Radiol. 1994;49(12):867-870.
19. Klein I, Danzi S. Thyroid disease and the heart [published correction appears in Circulation. 2008;117(3):e18]. Circulation. 2007;116(15):1725-1735.
20. Seiler L, Rump LC, Schulte-Mönting J, et al. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. Eur J Endocrinol. 2004;150(3):329-337.
21. Mosso L, Carvajal C, González A, et al. Primary aldosteronism and hypertensive disease. Hypertension. 2003;42(2):161-165.
22. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis. 2001;37(4):699-705.
23. Eide IK, Torjesen PA, Drolsum A, Babovic A, Lilledahl NP. Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. J Hypertens. 2004;22(11):2217-2226.
24. Myint KS, Watts M, Appleton DS, et al. Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension. J Renin Angiotensin Aldosterone Syst. 2008;9(2):103-106.
25. Funder JW, Carey RM, Fardella C, et al.; Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(9):3266-3281.
26. Mulgrew AT, Fox N, Ayas NT, Ryan CF. Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study. Ann Intern Med. 2007;146(3):157-166.
27. Magiakou MA, Smyrnaki P, Chrousos GP. Hypertension in Cushing's syndrome. Best Pract Res Clin Endocrinol Metab. 2006;20(3):467-482.
28. Viera AJ, Hinderliter AL. Evaluation and management of the patient with difficult-to-control or resistant hypertension. Am Fam Physician. 2009;79(10):863-869.
29. Grossman E, Messerli FH. Secondary hypertension: interfering substances. J Clin Hypertens (Greenwich). 2008;10(7):556-566.
30. Arar MY, Hogg RJ, Arant BS Jr, Seikaly MG. Etiology of sustained hypertension in children in the southwestern United States. Pediatr Nephrol. 1994;8(2):186-189.
31. Flynn JT. Evaluation and management of hypertension in childhood. Prog Pediatr Cardiol. 2001;12(2):177-188.
32. Streeten DH, Anderson GH, Elias MF. Prevalence of secondary hypertension and unusual aspects of the treatment of hypertension in elderly individuals. Geriatr Nephrol Urol. 1992;2(2):91-98.
33. Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: a secondary cause of isolated systolic hypertension. J Clin Hypertens (Greenwich). 2006;8(8):596-599.
34. Haas DC, Foster GL, Nieto FJ, et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation. 2005;111(5):614-621.
35. Simoes e Silva AC, Silva JM, Diniz JS, et al. Risk of hypertension in primary vesicoureteral reflux. Pediatr Nephrol. 2007;22(3):459-462.
36. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. First of two parts. N Engl J Med. 2000;342(4):256-263.
37. Giuffre M, Ryerson L, Chapple D, Crawford S, Harder J, Leung AK. Nonductal dependent coarctation: a 20-year study of morbidity and mortality comparing early-to-late surgical repair. J Natl Med Assoc. 2005;97(3):352-356.
38. Börgel J, Springer S, Ghafoor J, et al. Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence. Clin Res Cardiol. 2010;99(8):499-506.
39. Skomro RP, Gjevre J, Reid J, et al. Outcomes of home-based diagnosis and treatment of obstructive sleep apnea. Chest. 2010;138(2):257-263.
40. Baguet JP, Hammer L, Lévy P, et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens. 2005;23(3):521-527.
41. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease); endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. Circulation. 2006;113(11):1474-1547.
42. Wheatley K, Ives N, Gray R, et al.; ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953-1962.
43. O'Neill WC. Sonographic evaluation of renal failure. Am J Kidney Dis. 2000;35(6):1021-1038.